Wall Street Access Asset Management »

Lenz Therapeutics shares owned by Wall Street Access Asset Management

Quarter-by-quarter ownership of Lenz Therapeutics (LENZ) shares owned by Wall Street Access Asset Management from 13F filings

Historical chart of Wall Street Access Asset Management investment in Lenz Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lenz Therapeutics held by Wall Street Access Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lenz Therapeutics by Wall Street Access Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $493k 21k 23.74